Understanding Ascites and Its Classification
Ascites refers to the pathological accumulation of fluid within the peritoneal cavity, typically defined as more than 25 mL. The underlying cause may vary considerably—from advanced liver disease to malignancy to infection—and identifying the mechanism is essential for appropriate treatment.
Medical professionals assess ascitic fluid using two primary markers: the serum-ascites albumin gradient (SAAG) and ascitic fluid total protein (AFTP). While AFTP helps classify fluid as transudate or exudate based on protein content and vessel integrity, SAAG is the superior marker for diagnosing portal hypertension. Portal hypertension accounts for roughly 80% of ascites cases in developed nations, making SAAG calculation a cornerstone of diagnostic evaluation.
The SAAG Calculation
SAAG is straightforward to compute: subtract the albumin concentration in ascitic fluid from the serum albumin concentration. Both measurements must be performed simultaneously, as albumin levels fluctuate during treatment and can compromise accuracy if samples are drawn at different times.
SAAG (g/dL) = Serum albumin − Ascitic fluid albumin
Example: 4.23 g/dL − 3.54 g/dL = 0.69 g/dL
Serum albumin— Albumin concentration measured in blood serum (typically 3.5–5.5 g/dL)Ascitic fluid albumin— Albumin concentration measured in the peritoneal fluid sample
Interpreting SAAG Results
SAAG thresholds reliably predict the underlying mechanism of ascites formation:
- SAAG ≥ 1.1 g/dL (≥ 11 g/L): Indicates portal hypertension with 97% diagnostic accuracy. Causes include cirrhosis, hepatic venous outflow obstruction (Budd-Chiari syndrome), and portal vein thrombosis.
- SAAG < 1.1 g/dL (< 11 g/L): Suggests non-portal pathology. Differential diagnoses include peritoneal malignancy, spontaneous bacterial peritonitis, tuberculosis, pancreatitis, and nephrotic syndrome.
Notably, SAAG remains reliable even when ascites is concentrated by diuretic therapy or dialysis, because the gradient persists as long as the underlying pathophysiological mechanism remains unchanged.
Critical Considerations When Using SAAG
Proper interpretation of SAAG requires awareness of several clinical nuances that affect accuracy and clinical utility.
- Simultaneous sampling is mandatory — Albumin concentrations shift during treatment, fluid shifts, and dietary changes. Obtaining serum and ascitic fluid samples at different times invalidates the gradient and can lead to misdiagnosis. Mark both tubes with the exact time of collection.
- Portal hypertension may coexist with other causes — A patient can have SAAG ≥ 1.1 g/dL from cirrhosis AND secondary ascitic infection or malignant involvement. SAAG alone does not exclude additional pathology; integrate clinical findings, imaging, and ascitic fluid analysis (cell counts, culture, cytology).
- Albumin levels affect calcium correction — Abnormal serum albumin in the setting of ascites distorts measured serum calcium. When interpreting laboratory results, use albumin-corrected calcium values rather than total calcium to avoid false diagnosis of hypercalcaemia or hypocalcaemia.
- SAAG may normalise after treatment — Successful portal hypertension management (e.g., transjugular intrahepatic portosystemic shunt) can lower SAAG below 1.1 g/dL. Repeat measurement helps assess treatment response but should not be used immediately after acute interventions when fluid dynamics are still unstable.
Clinical Context and Next Steps
Once SAAG categorises ascites aetiology, further diagnostic workup depends on the result. High SAAG ascites warrants imaging (ultrasound or CT) to assess liver parenchyma, portal vein patency, and spleen size. Low SAAG ascites demands ascitic fluid cell counts, cultures, tumour markers, and potentially peritoneal biopsy if tuberculosis or malignancy is suspected.
Management differs markedly: portal hypertension is treated with vasoactive drugs and salt restriction, whereas peritoneal malignancy may require chemotherapy, and infection requires antibiotics. SAAG guides this triage efficiently, making it one of the most cost-effective and clinically valuable tests in hepatology and peritoneal disease assessment.